Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - OTHER CURRENT LIABILITIES
Other Current Liabilities ITCI - Intra-Cellular Therapies, Inc.
108 M
LAST VALUE
69.11%
2 YEAR CAGR
37.17%
5 YEAR CAGR
41.22%
10 YEAR CAGR